JCV-DNA testing during natalizumab treatment is complementary to anti-JCV antibodies for PML risk stratification

MULTIPLE SCLEROSIS JOURNAL(2011)

Cited 0|Views0
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined